Elecsys pTau217 plasma immunoassay detection of amyloid pathology in clinical cohorts
Roche Pharma AG (Germany) · Roche (Switzerland) · +8 more institutions
Indexed incrossrefpubmed
Abstract
Introduction
Phospho-Tau (217P) plasma immunoassay (Roche Diagnostics) for detecting amyloid pathology.
Methods
Plasma tau phosphorylated at threonine 217 (pTau217) levels were determined in samples from cognitively impaired and unimpaired individuals from five cohorts (N = 2148) using the pTau217 plasma immunoassay. Clinical performance was evaluated against amyloid positron emission tomography.
Citation impact
4
total citations
- FWCI
- 67.49
- Percentile
- 99%
- References
- 31
Too recent for citation history.
Authors
12Topics & keywords
Topics
Keywords
- Immunoassay
- Predictive value
- Amyloid (mycology)
- Disease
- Radioimmunoassay
No related works found for this paper.